ICON Shares Outstanding 2010-2025 | ICLR

ICON shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ICON shares outstanding for the quarter ending March 31, 2025 were 0.081B, a 2.79% decline year-over-year.
  • ICON 2024 shares outstanding were 0.083B, a 0.38% increase from 2023.
  • ICON 2023 shares outstanding were 0.083B, a 0.3% increase from 2022.
  • ICON 2022 shares outstanding were 0.082B, a 21.16% increase from 2021.
ICON Annual Shares Outstanding
(Millions of Shares)
2024 83
2023 83
2022 82
2021 68
2020 53
2019 54
2018 55
2017 55
2016 56
2015 60
2014 63
2013 62
2012 60
2011 61
2010 61
2009 60
ICON Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 81
2024-12-31 83
2024-09-30 83
2024-06-30 83
2024-03-31 83
2023-12-31 83
2023-09-30 83
2023-06-30 83
2023-03-31 83
2022-12-31 82
2022-09-30 82
2022-06-30 82
2022-03-31 83
2021-12-31 68
2021-09-30 81
2021-06-30 53
2021-03-31 53
2020-12-31 53
2020-09-30 53
2020-06-30 53
2020-03-31 54
2019-12-31 54
2019-09-30 55
2019-06-30 54
2019-03-31 54
2018-12-31 55
2018-09-30 55
2018-06-30 55
2018-03-31 55
2017-12-31 55
2017-09-30 55
2017-06-30 55
2017-03-31 55
2016-12-31 56
2016-09-30 57
2016-06-30 57
2016-03-31 56
2015-12-31 60
2015-09-30 60
2015-06-30 62
2015-03-31 62
2014-12-31 62
2014-09-30 63
2014-06-30 63
2014-03-31 63
2013-12-31 63
2013-09-30 62
2013-06-30 62
2013-03-31 61
2012-12-31 61
2012-09-30 60
2012-06-30 61
2012-03-31 61
2011-12-31 61
2011-09-30 61
2011-06-30 61
2011-03-31 61
2010-12-31 61
2010-09-30 61
2010-06-30 61
2010-03-31 60
2009-12-31 60
2009-09-30 60
2009-06-30 60
2009-03-31 60
Sector Industry Market Cap Revenue
Medical Medical Services $10.225B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.694B 25.08
Elevance Health (ELV) United States $90.401B 11.66
CVS Health (CVS) United States $78.570B 9.77
Cencora (COR) United States $56.472B 19.65
DiDi Global (DIDIY) China $22.450B 34.07
Natera (NTRA) United States $20.631B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.588B 13.33
EUROFINS SCIENT (ERFSF) Luxembourg $12.514B 0.00
CochLear (CHEOY) Australia $11.382B 0.00
Revvity (RVTY) United States $10.588B 18.22
Viatris (VTRS) United States $9.953B 3.42
Doximity (DOCS) United States $9.475B 44.13
Avantor (AVTR) United States $8.552B 12.43
HealthEquity (HQY) United States $8.545B 42.04
Medpace Holdings (MEDP) United States $8.501B 22.58
Sonic Healthcare (SKHHY) Australia $8.263B 0.00
Charles River Laboratories (CRL) United States $6.630B 12.99
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.137B 38.29
Bausch + Lomb (BLCO) Canada $3.955B 23.31
Sotera Health (SHC) United States $3.503B 19.90
Alignment Healthcare (ALHC) United States $3.033B 0.00
Surgery Partners (SGRY) United States $2.905B 37.78
Concentras Parent (CON) United States $2.803B 16.20
Organon (OGN) United States $2.191B 2.33
Ardent Health Partners (ARDT) United States $2.137B 9.11
GeneDx Holdings (WGS) United States $1.934B 74.48
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.816B 39.98
PACS (PACS) United States $1.506B 0.00
GoodRx Holdings (GDRX) United States $1.354B 27.07
Pediatrix Medical (MD) United States $1.303B 9.91
Teladoc Health (TDOC) United States $1.223B 0.00
Establishment Labs Holdings (ESTA) $1.037B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
Agilon Health (AGL) United States $0.973B 0.00
CareDx (CDNA) United States $0.949B 14.83
Nutex Health (NUTX) United States $0.941B 14.21
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.722B 4.86
InnovAge Holding (INNV) United States $0.554B 0.00
Enhabit (EHAB) United States $0.528B 43.46
Auna S.A (AUNA) Luxembourg $0.506B 11.40
LifeMD (LFMD) United States $0.489B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.403B 0.00
SBC Medicals (SBC) United States $0.360B 0.00
Performant Healthcare (PHLT) United States $0.204B 0.00
Oncology Institute (TOI) United States $0.202B 0.00
Beauty Health (SKIN) United States $0.195B 0.00
KindlyMD (KDLY) United States $0.137B 0.00
DocGo (DCGO) United States $0.131B 21.33
So-Young (SY) China $0.089B 0.00
OncoCyte (OCX) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.072B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
Biodesix (BDSX) United States $0.058B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00